USPTO 2015–2025 USPTO PatentsView Foreign Corporation

B-K Medical APS

USPTO PatentsView assignee record — 89 granted patents across 15 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).

89
Total patents granted
15
CPC technology areas
20.8
Avg claims per patent
+54%
5-year filing velocity

The verdict

B-K holds 89 US patents across 15 technology areas — rank #4,029 of 50,000 tracked assignees.

#4,029
of 50,000 US assignees by volume
Top 22%
by Innovation Score (46.0/100)
20.8
avg claims per patent
+54%
filing velocity, last 5 yrs

Portfolio overview

B-K MEDICAL APS has been granted 89 US utility patents between 2015 and 2025, placing B-K MEDICAL APS at rank #4,029 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 20.8 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a Foreign Corporation, B-K MEDICAL APS is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 46.0/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 54 grants, compared with 35 in the 2015–2019 window — a +54% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. B-K MEDICAL APS's 20.8 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark B-K MEDICAL APS against peers pursuing similar technology classes.

How does B-K compare?

Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀

patents

What this shows B-K holds 89 patents — placing it at rank #4,029 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView — granted utility patents As of 2015–2025

B-K's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

46 Top 22% higher than 78% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView — PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

05101520 20152016201720182019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
B-K MEDICAL APS patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 2 2.2%
2016 6 6.7%
2017 9 10.1%
2018 7 7.9%
2019 11 12.4%
2020 16 18.0%
2021 12 13.5%
2022 10 11.2%
2023 9 10.1%
2024 6 6.7%
2025 1 1.1%

Which technologies does B-K MEDICAL APS patent most?

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#4,029

Across all tracked assignees

Innovation Score

46.0 out of 100

View all rankings →

Data Source

USPTO PatentsView — US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does B-K MEDICAL APS hold?
B-K MEDICAL APS holds 89 US granted patents filed between 2015 and 2025, spanning 15 technology areas.
What is B-K MEDICAL APS's Innovation Score?
B-K MEDICAL APS has an Innovation Score of 46.0 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does B-K MEDICAL APS focus on?
B-K MEDICAL APS's top technology area is A61B (DIAGNOSIS; SURGERY; IDENTIFICATION) with 68 patents. The company has filed patents in 15 CPC subclasses total.
Is B-K MEDICAL APS's patent filing rate increasing or decreasing?
B-K MEDICAL APS's recent filing velocity is +54% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for B-K MEDICAL APS's patents?
B-K MEDICAL APS's patents average 20.8 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the B-K MEDICAL APS patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Learn More

How to use this portfolio

B-K's 89 grants land it in the top 22% by Innovation Score — but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance — B-K ranks #4,029 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61B — see who else leads that technology area. A61B leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity — not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView — official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView — the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) — the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search — the official interface to verify the status of any individual patent. ppubs.uspto.gov